Publicaciones (125) Publicaciones de GUILLERMO VELASCO DÍEZ

2024

  1. Cellular stress responses as modulators of drug cytotoxicity in pharmacotherapy of glioblastoma

    Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1879, Núm. 1

  2. Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle

    Cancer Letters, Vol. 585

  3. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1

    Molecular Oncology, Vol. 18, Núm. 3, pp. 620-640

  4. Preparation and characterization of PBS (Polybutylene Succinate) nanoparticles containing cannabidiol (CBD) for anticancer application

    Journal of Drug Delivery Science and Technology, Vol. 97

  5. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. Ludificación y mentoría en Ingeniería Genética: construcción de unjuego docente sobre la infraestructura LAMP

    II Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 41-52

  2. Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers

    Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581

  3. Preparation and characterization of full-spectrum cannabis extract loaded poly(thioether-ester) nanoparticles: In vitro evaluation of their antitumoral efficacy

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 658

  4. Pseudokinases, Tribbles Proteins and Cancer

    Cancers

2022

  1. Editorial: Molecular Mechanisms of Autophagy in Cancer

    Frontiers in Cell and Developmental Biology

  2. Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial

    Cancers, Vol. 14, Núm. 10

  3. TRIB1 regulates tumor growth via controlling tumorassociated macrophage phenotypes and is associated with breast cancer survival and treatment response

    Theranostics, Vol. 12, Núm. 8, pp. 3584-3600

  4. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells

    International journal of molecular sciences, Vol. 23, Núm. 18

  5. The phantom menace: cómo salvar el mundo de una pandemia mediante ingeniería genética cooperativa.

    Jornada «Aprendizaje Eficaz con TIC en la UCM» (Universidad Complutense de Madrid), pp. 301-311

  6. Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates

    Frontiers in Immunology, Vol. 12

2021

  1. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity

    Nature, Vol. 592, Núm. 7856, pp. 799-803

  2. Cancer Treatment: Preclinical & Clinical

    Journal of the National Cancer Institute - Monographs, Vol. 2021, Núm. 58, pp. 107-113

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells

    Autophagy, Vol. 17, Núm. 6, pp. 1349-1366

  5. The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer

    Cancers, Vol. 13, Núm. 21